drugset / Trial / NCT00567203
A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia
RandomizedCrossoverTriple-blindTreatment
Summary
The objective of this study is to evaluate the safety, tolerability, and efficacy of two dose regimens of PF-3463275 compared with placebo added to ongoing atypical antipsychotic therapy for cognitive deficits in subjects with chronic symptoms of schizophrenia.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03463275 | Small molecule | 10 mg | — |
| Subject | PF-03463275 | Small molecule | 25 mg | — |